Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 06-2008 | 06-2007 | 06-2006 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 15 | -16 | 20 | 136 | -146 |
| Other Working Capital | 79 | 93 | 97 | 56 | 34 |
| Other Operating Activity | -2,448 | -2,323 | -1,825 | -1,325 | -532 |
| Operating Cash Flow | $-2,354 | $-2,246 | $-1,708 | $-1,133 | $-644 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -69 | -126 | -52 | -60 |
| Other Investing Activity | 1,644 | 1,855 | 2,523 | 1,141 | -8,255 |
| Investing Cash Flow | $1,560 | $1,786 | $2,397 | $1,089 | $-8,315 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,357 | N/A | N/A | N/A | 10,000 |
| Other Financing Activity | -157 | -3 | -3 | -1 | -1,020 |
| Financing Cash Flow | $6,200 | $-3 | $-3 | $-1 | $8,980 |
| Beginning Cash Position | 557 | 1,020 | 334 | 8,683 | 407 |
| End Cash Position | 5,963 | 557 | 1,020 | 7,484 | 8,683 |
| Net Cash Flow | $5,406 | $-463 | $686 | $-45 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,354 | -2,246 | -1,708 | -1,133 | -644 |
| Capital Expenditure | -84 | -69 | -126 | -52 | -60 |
| Free Cash Flow | -2,438 | -2,315 | -1,834 | -1,185 | -704 |